Related Experiment Videos
Morphologic and molecular cytogenetics in neuroblastoma
H Avet-Loiseau1, A M Venuat, J Benard
1Laboratoire de Cytogénétique et Génétique Oncologiques, Institut Gustave Roussy, France.
Cancer
|April 1, 1995
Summary
Genetic alterations like MYCN amplification impact neuroblastoma prognosis. Fluorescent in situ hybridization (FISH) is a rapid, recommended method for assessing MYCN amplification in pediatric neuroblastoma patients.
Area of Science:
- Pediatric Oncology
- Cancer Genetics
- Molecular Diagnostics
Background:
- Neuroblastoma prognosis is influenced by specific genetic alterations.
- Key prognostic factors include MYCN oncogene amplification, chromosome 1p deletion, and ploidy.
- Understanding these genetic markers is crucial for patient stratification.
Purpose of the Study:
- To investigate the prognostic implications of MYCN amplification, 1p deletion, and ploidy in pediatric neuroblastoma.
- To compare diagnostic methods for MYCN amplification.
- To evaluate the utility of these genetic factors in clinical management.
Main Methods:
- Analysis of 20 neuroblastoma samples using morphologic cytogenetics.
- MYCN amplification status determined by Southern blot and fluorescent in situ hybridization (FISH).
- Comparison of FISH and Southern blot for MYCN amplification detection.
Main Results:
- Complete karyotype obtained for 14 patients.
- Diploid/tetraploid mode and 1p deletion observed in advanced-stage neuroblastoma.
- High concordance between Southern blot and FISH for MYCN amplification, even at low levels.
- Demonstrated significant intercellular variation in MYCN amplification levels within samples.
Conclusions:
- Fluorescent in situ hybridization (FISH) is a recommended rapid method for assessing MYCN amplification in neuroblastoma.
- FISH is valuable for therapeutic protocols guided by MYCN status, particularly for infants and localized tumors.
- Genetic profiling aids in tailoring treatment strategies for neuroblastoma.